Bausch Health Files 8-K on Financials
Ticker: BHC · Form: 8-K · Filed: Jul 30, 2025 · CIK: 885590
Sentiment: neutral
Topics: financial-reporting, results-of-operations
TL;DR
Bausch Health dropped an 8-K on July 30th detailing their financial results. Check it out.
AI Summary
Bausch Health Companies Inc. filed an 8-K on July 30, 2025, reporting on its results of operations and financial condition. The filing includes financial statements and exhibits related to the company's performance. Bausch Health Companies Inc. was formerly known as Valeant Pharmaceuticals International, Inc. and BIOVAIL Corp.
Why It Matters
This filing provides crucial updates on Bausch Health's financial performance and condition, which can impact investor decisions and market perception.
Risk Assessment
Risk Level: low — This is a routine financial reporting filing and does not indicate any immediate operational or financial distress.
Key Players & Entities
- Bausch Health Companies Inc. (company) — Registrant
- Valeant Pharmaceuticals International, Inc. (company) — Former company name
- BIOVAIL Corp (company) — Former company name
- July 30, 2025 (date) — Date of report
FAQ
What specific financial information is detailed in this 8-K filing?
The filing indicates it covers 'Results of Operations and Financial Condition' and includes 'Financial Statements and Exhibits', but the specific details of these results are not provided in the excerpt.
When was this 8-K report filed?
The report was filed on July 30, 2025.
What are the previous names of Bausch Health Companies Inc. mentioned in the filing?
The filing states that Bausch Health Companies Inc. was formerly known as Valeant Pharmaceuticals International, Inc. and BIOVAIL Corp.
What is the principal executive office address for Bausch Health Companies Inc.?
The principal executive offices are located at 2150 St. Elzéar Blvd. West, Laval, Québec, Canada H7L 4A8.
Under which section of the Securities Exchange Act of 1934 is this 8-K filed?
This 8-K is filed pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on July 30, 2025 regarding Bausch Health Companies Inc. (BHC).